EGFR and colorectal carcinoma: This technology may complement immunohistochemical assessment of EGFR protein expression in CRC tissue which might contribute to future standardization methods measuring EGFR protein level, to improve the identification of patients who will benefit from anti-EGFR monoclonal antibody therapy.